Cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Uncontrolled Cell Division – Cancer arises when genetic mutations disrupt normal cell cycle regulation, leading to unchecked cell proliferation. Mutations in tumor suppressor genes (e.g., p53) or oncogenes (e.g., HER2) can drive this process, allowing cells to bypass growth controls.

• Secondary mechanism: Evasion of Apoptosis – Cancer cells often acquire the ability to avoid programmed cell death. This survival advantage is frequently due to alterations in apoptotic pathways, such as overexpression of anti-apoptotic proteins like Bcl-2, which prevents the elimination of damaged or abnormal cells.

• Key complication: Metastasis – Cancer cells can invade surrounding tissues and spread to distant organs through the bloodstream or lymphatic system. This process involves changes in cell adhesion and the extracellular matrix, significantly complicating treatment and worsening prognosis due to the establishment of secondary tumors.

Patient Profile

Demographics:

58-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Breast Cancer (Stage II) diagnosed 18 months ago

• Current medications: Lisinopril 20 mg daily, Metformin 500 mg twice daily, Letrozole 2.5 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent cough and shortness of breath

• Key symptoms: Fatigue, weight loss, night sweats, occasional chest pain

• Vital signs: Blood pressure 145/90 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 92% on room air

Section 1

New Diagnostic Results:

Following the patient's presentation with persistent cough, shortness of breath, and other systemic symptoms, further diagnostic evaluations were conducted to assess potential metastatic progression. A chest X-ray revealed the presence of multiple nodular opacities in both lung fields, suggesting possible pulmonary metastases. A subsequent CT scan of the chest confirmed these findings, showing several lesions with a "ground-glass" appearance, indicative of metastatic spread from the primary breast cancer. Additionally, a PET scan was performed, which demonstrated increased metabolic activity in these lung lesions as well as in the liver, raising concerns about further metastatic involvement.

Laboratory tests were also ordered to provide further information. Her complete blood count indicated mild anemia with a hemoglobin level of 10.5 g/dL, which might be contributing to her fatigue. Liver function tests showed elevated levels of alkaline phosphatase and gamma-glutamyl transferase, suggesting hepatic involvement. Tumor marker tests revealed an increased CA 15-3 level, supporting the suspicion of disease progression.

These diagnostic results necessitate a reevaluation of the patient's treatment plan, considering the evidence of metastatic disease. The oncology team discusses potential options, including systemic chemotherapy, targeted therapy adjustments, or participation in clinical trials. The patient's current symptoms and test findings highlight the need for interdisciplinary management to address both the cancer's direct effects and the secondary complications, such as respiratory compromise and potential liver dysfunction. The team must also consider the patient's comorbid conditions, like hypertension and diabetes, when planning the next steps in her care.

Section 2

Change in Patient Status:

In the weeks following the confirmation of metastatic spread, the patient has experienced a noticeable decline in her respiratory status. She now presents with increased shortness of breath and requires supplemental oxygen to maintain adequate saturation levels. During her latest clinic visit, the patient reported worsening fatigue and a new onset of peripheral edema. On examination, her vital signs showed a respiratory rate of 24 breaths per minute, oxygen saturation at 88% on room air, and a heart rate of 110 beats per minute. Auscultation of the lungs revealed bilateral crackles, consistent with fluid overload and possible pulmonary edema secondary to cardiac strain or hepatic impairment.

The nursing team conducted a focused assessment and noted that the patient exhibited jugular venous distention and hepatomegaly, suggesting potential right-sided heart failure or worsening liver involvement. Laboratory tests revealed further decreases in hemoglobin to 9.8 g/dL, indicating progressive anemia, and elevated levels of bilirubin and transaminases, confirming liver dysfunction. These findings raised concerns about the combined impact of metastatic disease on her cardiopulmonary and hepatic systems.

In response to these changes, the oncology team is considering the initiation of diuretic therapy to manage the fluid overload and improve respiratory function. A referral to a cardiologist is planned to evaluate cardiac function and potential heart failure. The patient's treatment plan is being re-evaluated to include therapies that address both her cancer and the secondary complications, with a focus on improving her quality of life. This situation requires careful clinical reasoning to balance aggressive cancer treatment with supportive care measures aimed at mitigating her current symptoms and preventing further deterioration.

Section 3

As the nursing team continued to monitor the patient's condition, a change in her status became evident. Despite the introduction of diuretic therapy, her peripheral edema showed minimal improvement. The patient's respiratory distress persisted, and her oxygen saturation remained borderline, even with increased supplemental oxygen. During a routine assessment, her respiratory rate was recorded at 28 breaths per minute, with an oxygen saturation of 90% on 3 liters of oxygen. Her heart rate increased to 118 beats per minute, and blood pressure was noted at 100/60 mmHg, indicating potential hemodynamic instability.

Laboratory investigations revealed further deterioration in liver function, with bilirubin levels rising to 3.5 mg/dL and transaminases continuing to trend upward. Additionally, her serum creatinine level increased to 1.8 mg/dL, suggesting renal impairment, possibly secondary to diuretic use or as a result of her underlying condition. These findings raised concerns for multisystem involvement, prompting the need to reassess her current management plan.

The oncology and cardiology teams convened to discuss the patient's complex clinical picture. The decision was made to adjust her diuretic regimen cautiously to avoid exacerbating renal insufficiency while addressing fluid overload. The patient's chemotherapy regimen was reviewed to consider potential modifications that might alleviate hepatic strain. Emphasis was placed on supportive interventions to optimize her comfort and quality of life, with plans for more frequent monitoring and re-evaluation to quickly identify and respond to any further complications.

Section 4

The patient’s condition continued to evolve, and the team remained vigilant in monitoring for any new complications. Approximately 48 hours after the adjustments to her diuretic regimen, the patient exhibited a concerning change in her mental status. She became increasingly confused and lethargic, with episodes of disorientation and slurred speech. Her family reported that she seemed more forgetful and less responsive to their questions. A focused neurological assessment revealed that she was oriented only to person and demonstrated asterixis, suggesting hepatic encephalopathy—a complication likely linked to her worsening liver function.

Concurrent with these neurological changes, the patient developed mild jaundice, and her abdominal examination revealed a tense, distended abdomen with shifting dullness, indicating ascites. Repeat laboratory tests showed an increase in ammonia levels to 85 µmol/L, reinforcing the suspicion of hepatic encephalopathy. Her renal function remained compromised, with serum creatinine rising slightly to 2.0 mg/dL. In response to these findings, the medical team prioritized measures to address her hepatic encephalopathy. Lactulose therapy was initiated to help reduce ammonia levels, and her fluid status was carefully balanced to manage both ascites and renal function.

The patient’s respiratory status remained precarious, with her oxygen saturation fluctuating between 88-90% despite supplemental oxygen. This prompted the team to initiate a discussion on the potential need for non-invasive ventilation to support her respiratory function while continuing to monitor her hemodynamics closely. The focus remained on providing comprehensive supportive care, anticipating further complications, and ensuring that interventions were aligned with the patient's goals of care. The next steps involved close observation for signs of improvement or further decline, with a commitment to dynamic reassessment and timely decision-making.

Section 5

Approximately 24 hours after initiating lactulose therapy, the patient's condition began to show a mixed response. Her mental status exhibited slight improvement; she was marginally more responsive and oriented to person and place, though still displayed episodes of confusion. Repeat ammonia levels showed a modest decrease to 70 µmol/L, indicating a partial response to the treatment. However, her jaundice appeared more pronounced, and her abdominal distention remained significant despite attempts to manage her fluid balance. Vital signs revealed a blood pressure of 100/60 mmHg, heart rate of 105 bpm, and persistent oxygen saturation in the range of 88-90% on 4L/min nasal cannula. Her respiratory rate increased to 24 breaths per minute, indicating possible respiratory distress.

The team conducted further diagnostic tests, including a chest X-ray, which showed bilateral pleural effusions, contributing to her respiratory compromise. A diagnostic paracentesis was performed, confirming high protein, low SAAG ascitic fluid, suggestive of malignant ascites, likely secondary to her underlying cancer. The findings prompted the team to reassess her treatment plan, considering the potential need for therapeutic paracentesis to relieve discomfort and improve respiratory function. Concurrently, the rising creatinine level, now at 2.2 mg/dL, necessitated a delicate approach to fluid management to prevent further renal deterioration.

With these new complications, the multidisciplinary team engaged in a comprehensive discussion with the patient and her family about realistic goals of care, emphasizing the importance of aligning interventions with her preferences and quality of life considerations. The focus shifted towards optimizing symptom management, with careful monitoring of her fluid status, ongoing lactulose therapy, and potential escalation to non-invasive ventilation to support her breathing. The evolving clinical picture required dynamic reassessment and timely adaptation of the care plan, aiming to anticipate further complications and ensure that the patient received compassionate, patient-centered care.